ArticleFrontiers in oncology2021

Impact of COVID-19 Pandemic on Intervals and Outcomes of Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma.

Zhi-Cheng Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.